Teva Pharmaceutical Industries Reaches Analyst Target Price
November 20, 2017 at 08:34 AM EST
In recent trading, shares of Teva Pharmaceutical Industries Ltd (TEVA) have crossed above the average analyst 12-month target price of $13.80, changing hands for $13.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..